Live IPO - Cronos Australia Ltd.


Cronos Australia Ltd (ASX:CAU) is a medicinal cannabis company that plans to enter the medicinal cannabis market in Australia with both THC and CBD cannabis products. Cronos Australia has secured all the necessary Australian licences to operate – including import and export licences. In addition to distributing the in-market brand PEACE NATURALS™, which is sold in Canada and Germany, Cronos Australia intends to also engage in product and brand development, outsourced manufacturing and distribution for Australia and target export markets in Asia (subject to legislative reform in those markets and Cronos Australia obtaining any required approvals and licences)

  • Offer Open: October 16

  • Pay By: OCtober 25

  • List Price: $0.50

  • Minimum Investment: $2,000

  • Raising: $20M

  • Market Cap: 64.4M AUD

  • Lead Manager: Bell Potter

  • Prospectus

Bid Now.

Live IPO - Latitude Financial Group Limited (CommSec)


Latitude is a leading digital payments, instalments and lending platform, with 2.6 million customer accounts and more than 1,950 merchant partners across Australia and New Zealand. Latitude was formerly owned by GE, under which it developed sophisticated risk management capabilities, an extensive network of merchants and a significant internal bureau of customer data.

These capabilities, combined with significant funding capacity, have enabled Latitude to deliver strong growth and stable returns, with a forecast Adjusted Return on Equity of ~20% for the six months ending 30 June 2020 on an annualised basis.

Please note, this listing was obained via CommSec and you must be a CommSec customer to participate in this offer. Your broker may also have an opportunity to participate, please contact them.

  • Prospectucs Lodgement Date: 26th September 2019

  • Broker Firm Offer Opens: 4th October 2019

  • Broker Firm Offer Closes: 14th October 2019

  • Expected Commencement: 25th October 2019

  • Price Range: $2 - $2.25

  • Minimum Investment: $2,000

  • Market Cap: 3.5-4bn

  • Lead Managers: Goldman Sachs, Macquarie, UBS

  • Prospectus

Bid Now


Live IPO - Imricor Medical Systems, Inc.


Imricor Medical Systems, Inc. (ASX:IMR) is a U.S.-based medical device company, focused on designing, manufacturing and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Imricor believes it will be the first company in the world to bring commercially viable and safe MRI-compatible products to the cardiac catheter ablation market.

Imricor currently has 18 issued U.S. patents, 40 corresponding granted foreign patents and 2 foreign patent applications that have been allowed.

Imricor currently generates revenue from licensing IP for use in implantable devices and a contract research project in the area of MRI-guided interventions. However, given that the company has obtained CE mark approval to place one of its key products, the Advantage-MR EP Recorder/Stimulator System, on the market in the European Union, and is in the final stages of the CE mark approval process for its other key products, the Vision-MR Ablation Catheter (with an indication for treating type I atrial flutter) and the Vision-MR Dispersive Electrode, Imricor plans to establish a third revenue stream from the sale of these products. This third revenue stream is expected to become its primary revenue source, with forecast revenues of US$6.9 million for 2019.

  • Pay By: August 21st

  • List Price: $0.83

  • Minimum Investment: $2,000

  • Raising: $12-$13M AUD

  • Market Cap: 77M AUD

  • Lead Manager: Moelis Australia

  • Prospectus


Live IPO - Tartana Resources Limited.


Tartana Resources Limited (ASX: TNA) is a zinc and copper exploration company with assets being the Tartana Copper and Zinc Project in northern Queensland and the Zeehan Zinc Slag Project in western Tasmania.  The Tartana Project is the flagship project. It comprises four mining leases which contains an open pit which was the source of copper oxide ore for historical copper sulphate production using heap leach pads and a solvent extraction/crystallisation plant, still on site.

Past exploration on the mining leases has defined four separate exploration projects and mineralisation in each potentially relates to an interpreted deeper porphyry copper system. The projects are the Queen Grade Zinc Project comprising a zone of interpreted zinc skarn mineralisation, a Copper Oxide Project which is based on mineralisation evident within and around the existing open pit, a deeper Copper Sulphide Project below and to the north of the pit and lastly, the Valentino Copper/Gold/Silver/Cobalt Project which is further east but may also be related to the deeper sulphide mineralisation.

  • Pay By: Jul 26th

  • List Price: $0.20

  • Minimum Investment: $2,000

  • Raising: $4-$6M

  • Prospectus

Bid Now.